Kampanjeplan Tenaya Therapeutics, Inc.
Avansert tidsplan
Enkel graf
Om selskapet Tenaya Therapeutics, Inc.
Tenaya Therapeutics, Inc. разрабатывает препараты для лечения сердечной недостаточности. Он предлагает платформу клеточной регенерации, которая позволяет in vivo перепрограммировать сердечные фибробласты в кардиомиоциты путем доставки запатентованных факторов транскрипции; платформа генной терапии, позволяющая целенаправленно доставлять полезную нагрузку к сердечным фибробластам; и платформа точной медицины, которая обеспечивает индивидуальный подход к лечению сердечных заболеваний. Компания была зарегистрирована в 2016 году и базируется в Южном Сан-Франциско, Калифорния.IPO date | 2021-07-30 |
---|---|
ISIN | US87990A1060 |
Industry | Biotechnology |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.tenayatherapeutics.com |
Цена ао | 1.5 |
Prisendring per dag: | -3.97% (1.26) |
---|---|
Prisendring per uke: | -13.57% (1.4) |
Prisendring per måned: | -27.11% (1.66) |
Prisendring over 3 måneder: | -36.65% (1.91) |
Prisendring over seks måneder: | -67.47% (3.72) |
Prisendring per år: | -71.12% (4.19) |
Prisendring over 3 år: | -90.42% (12.63) |
Prisendring over 5 år: | 0% (1.21) |
Prisendring over 10 år: | 0% (1.21) |
Prisendring siden begynnelsen av året: | -14.18% (1.41) |
|
Undervurdering
|
Effektivitet
|
|||||||||||||||||||||||||||||||||||||
Utbytte
|
Plikt
|
Vekstimpuls
|
Institusjoner | Volum | Dele, % |
---|---|---|
Column Group LLC | 9 | 11.97 |
Casdin Capital, LLC | 7 | 8.58 |
Blackrock Inc. | 5 | 5.99 |
Price (T.Rowe) Associates Inc | 3 | 4.26 |
FMR, LLC | 3 | 3.71 |
Vanguard Group Inc | 3 | 3.65 |
Octagon Capital Advisors LP | 3 | 3.63 |
Integral Health Asset Management, LLC | 2 | 2.87 |
Citadel Advisors Llc | 2 | 2.86 |
VR Adviser, LLC | 2 | 1.98 |
ETF | Dele, % | Lønnsomhet for året, % | Utbytte, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.0295 | 17.09 | 1.54048 |
Avantis U.S Small Cap Equity ETF | 0.01822 | 27.77 | 1.68271 |
Vanguard Russell 2000 ETF | 0.01 | 17.16 | 1.48801 |
![]() |
0.00254 | 89.82 | 1.47873 |
![]() |
0.00246 | 38.04 | 0.6026 |
ProShares Hedge Replication ETF | 0.00068 | 5.92 | 1.47892 |
Dimensional U.S. Targeted Value ETF | 0.00035 | 26.01 | 1.93487 |
iShares Russell 3000 ETF | 0.00023 | 24.83 | 1.43482 |
Avantis U.S. Equity ETF | 0.0001 | 23.04 | 1.59151 |
Vanguard Russell 3000 ETF | 0 | 31.87 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0 | 23.05 | 0.60264 |
Veileder | Stillingstittel | Betaling | Fødselsår |
---|---|---|---|
Mr. Faraz Ali M.B.A. | CEO & Director | 816.39k | 1973 (52 år) |
Dr. Deepak Srivastava M.D. | Scientific Founder, Chairman of Scientific Advisory Board & Director | 118k | 1966 (59 år) |
Dr. Eric N. Olson Ph.D. | Scientific Founder & Member of Scientific Advisory Board | N/A | |
Dr. Bruce R. Conklin | Scientific Founder | N/A | |
Dr. Benoit G. Bruneau Ph.D. | Scientific Founder | N/A | |
Dr. Whittemore G. Tingley M.D., PH.D. | Chief Medical Officer | 621.98k | 1968 (57 år) |
Dr. Saptarsi Haldar M.D. | Scientific Founder | N/A | |
Dr. Sheng Ding Ph.D. | Scientific Founder | N/A | |
Ms. Chihiro Saito | Senior Accounting & Financial Operations and Interim Principal Accounting Officer | 1966 (59 år) | |
Dr. Kee-Hong Kim Ph.D. | Chief Technology Officer | 1966 (59 år) |
Adresse: United States, South San Francisco, CA , 171 Oyster Point Boulevard - åpne i Google maps, åpne Yandex-kart
Nettsted: https://www.tenayatherapeutics.com
Nettsted: https://www.tenayatherapeutics.com